José Manuel
Aramendía Beitia
Consultor Médico
Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (1)
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12